In a recent trial, researchers may have found a safe and effective alternative treatment for certain breast cancer patients who are not suited for systemic chemotherapy. For results of the trial, including...
A recent randomized trial compared radical prostatectomy with observation on long-term mortality outcomes and adverse events among men with localized prostate cancer.
After the results from a phase III randomized trial demonstrated its efficacy, the American Society of Clinical Oncology updated its guidelines to include a new genomic test. For information regarding...
In a recent study, researchers compared the efficacy of nivolumab with chemotherapy on clinical outcomes among patients with melanoma that progressed following ipilimumab therapy.
Several recent studies have suggested a potential relationship between regular physical activity and reduced risk of esophageal cancers. In a recent study, researchers investigated the magnitude of this...
The first-and-only fully human monoclonal anti-epidermal growth factor receptor antibody for the treatment of wild-type RAS metastatic colorectal cancer was recently approved by the US Food and Drug...
